Abstract
The chemical and biological properties of anti-inflammatory marine natural products whose mechanism of action involves inhibition of phospholipase A2 (PLA2), an enzyme of key importance in the biosynthesis of proinflammatory chemical signals and mediators, has been reviewed. Remarkably, most marine natural products display a selective inhibition profile against secretory PLA2 enzymes, with little or null ability to interfere with cytosolic PLA2. Variabilin, a marine furano-terpene, appears to be a notable exception, endowed with a distinctive dual inhibitor profile towards both secretory and cytosolic PLA2 proteins.
Keywords: inflammation, sesterterpenoids, manoalide, pla2 enzymes, cacospongionolides, luffariellolides, petrosaspongiolides
Current Organic Chemistry
Title: Chemistry and Biology of Anti-Inflammatory Marine Natural Products. Phospholipase A2 Inhibitors
Volume: 9 Issue: 14
Author(s): Luigi Gomez-Paloma, Maria C. Monti, Stefania Terracciano, Agostino Casapullo and Raffaele Riccio
Affiliation:
Keywords: inflammation, sesterterpenoids, manoalide, pla2 enzymes, cacospongionolides, luffariellolides, petrosaspongiolides
Abstract: The chemical and biological properties of anti-inflammatory marine natural products whose mechanism of action involves inhibition of phospholipase A2 (PLA2), an enzyme of key importance in the biosynthesis of proinflammatory chemical signals and mediators, has been reviewed. Remarkably, most marine natural products display a selective inhibition profile against secretory PLA2 enzymes, with little or null ability to interfere with cytosolic PLA2. Variabilin, a marine furano-terpene, appears to be a notable exception, endowed with a distinctive dual inhibitor profile towards both secretory and cytosolic PLA2 proteins.
Export Options
About this article
Cite this article as:
Gomez-Paloma Luigi, Monti C. Maria, Terracciano Stefania, Casapullo Agostino and Riccio Raffaele, Chemistry and Biology of Anti-Inflammatory Marine Natural Products. Phospholipase A2 Inhibitors, Current Organic Chemistry 2005; 9 (14) . https://dx.doi.org/10.2174/1385272054880205
DOI https://dx.doi.org/10.2174/1385272054880205 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Apoptosis Pathways and Neuroblastoma Therapy
Current Pharmaceutical Design Reactive Oxygen Species in the Initiation of IL-4 Driven Autoimmunity as a Potential Therapeutic Target
Current Pharmaceutical Design Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease
Current Cardiology Reviews Inflammation Drives Alzheimer's Disease: Emphasis on 5-lipoxygenase Pathways
Current Neuropharmacology Liverworts-Potential Source of Medicinal Compounds
Current Pharmaceutical Design Defense-related Proteins from Chelidonium majus L. as Important Components of its Latex
Current Protein & Peptide Science Gene Profile Identifies Zinc Transporters Differentially Expressed in Normal Human Organs and Human Pancreatic Cancer
Current Molecular Medicine Role of Interferons in Chronic Hepatitis C Infection
Current Drug Targets Potent Acetylcholinesterase Inhibitors: Potential Drugs for Alzheimer’s Disease
Mini-Reviews in Medicinal Chemistry Methicillin-Resistant <i>Staphylococcus aureus</i>: Treatment with Cultures of Non Drug-Resistant <i>Staphylococcus epidermidis</i>
Recent Patents on Anti-Infective Drug Discovery Interleukin-6 In Rheumatoid Arthritis - From The Laboratory To The Bedside
Current Pharmaceutical Design Genetic Manipulation of Human Embryonic Stem Cells: A System to Study Early Human Development and Potential Therapeutic Applications
Current Gene Therapy Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment
Current Pharmaceutical Design Revisiting proteus: Do Minor Changes in Lectin Structure Matter in Biological Activity? Lessons from and Potential Biotechnological Uses of the Diocleinae Subtribe Lectins
Current Protein & Peptide Science Chronic Pain: Cytokines, Lymphocytes and Chemokines
Inflammation & Allergy - Drug Targets (Discontinued) Targeting Hypoxia-Inducible Factor-1 (HIF-1) Signaling in Therapeutics: Implications for the Treatment of Inflammatory Bowel Disease
Recent Patents on Inflammation & Allergy Drug Discovery Early Functional and Structural Microvascular Changes in Hypertension Related to Aging
Current Hypertension Reviews Protease Inhibitors in the Clinic
Medicinal Chemistry Pigment Epithelium-derived Factor (PEDF) and Cardiometabolic Disorders
Current Pharmaceutical Design Ganoderma lucidum: A Potential for Biotechnological Production of Anti-Cancer and Immunomodulatory Drugs
Recent Patents on Anti-Cancer Drug Discovery